KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bio-Rad Laboratories (BIO) Leases (2019 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Leases for 7 consecutive years, with $170.0 million as the latest value for Q4 2025.

  • Quarterly Leases rose 5.92% to $170.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $170.0 million through Dec 2025, up 5.92% year-over-year, with the annual reading at $170.0 million for FY2025, 5.92% up from the prior year.
  • Leases for Q4 2025 was $170.0 million at Bio-Rad Laboratories, down from $180.3 million in the prior quarter.
  • The five-year high for Leases was $204.8 million in Q4 2021, with the low at $153.2 million in Q1 2025.
  • Average Leases over 5 years is $183.7 million, with a median of $183.3 million recorded in 2022.
  • The sharpest move saw Leases grew 16.56% in 2023, then decreased 18.91% in 2025.
  • Over 5 years, Leases stood at $204.8 million in 2021, then fell by 11.64% to $181.0 million in 2022, then rose by 7.6% to $194.7 million in 2023, then dropped by 17.57% to $160.5 million in 2024, then rose by 5.92% to $170.0 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $170.0 million, $180.3 million, and $190.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.